| abstract |
Disclosed are a disease marker reflecting a hormone-dependent cancer, a method for detecting a hormone-dependent cancer using the disease marker, and a method for screening a drug useful for improving the disease. ZNF339 gene, RPL4 gene, BRD3 gene, ERAP140 gene, ECH1 gene, PPARBP gene, STRN gene, ZIN gene, PERC gene, NR0B2 gene, TIF1A gene, NCOA1 gene, NCOA2 gene, NCOA6 gene, and / or NRIP1 A polynucleotide having at least 15 consecutive nucleotides in the nucleotide sequence of the gene and / or a polynucleotide complementary to the polynucleotide is used as a disease marker for hormone-dependent cancer. [Selection figure] None |